|
|
Marketing Authorisations
|
|
|
|
|
A bacterial enterotoxin derivative with a laxative action, nothing more
|
|
|
|
|
|
|
|
|
|
|
|
A fixed-dose combination with no advantage in COPD
|
|
|
|
|
|
|
|
|
|
An inadequately assessed combination of two cytotoxic drugs
|
|
|
|
Adverse Effects
|
|
|
|
|
Many risk factors
|
|
|
|
|
|
|
|
|
|
|
|
Confirmation of Prescrire's assessment
|
|
|
|
Reviews
|
|
|
|
|
Take resistance into account
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Choosing an empirical antibiotic treatment for a woman with acute uncomplicated pyelonephritis
|
|
|
|
|
|
|
|
|
|
Efficacy of levonorgestrel and ulipristal uncertain in overweight women
|
|
|
|
|
|
|
|
|
|